Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection

Abstract

Background The presentation of peptides and the subsequent immune response depend on the MHC characteristics and influence the specificity of the immune response. In addition to polymorphic T-cell receptor alpha/beta constructs, less variable T-cell receptor gamma/delta cells may respond to a specific peptide presented by MHC molecules of antigen presenting cells as well as other target tissues. Methods: High-resolution HLA typing was performed in 536 non-hospitalized patients infected with SARS-CoV2. For HLA-Class I we obtained results from 519 patients, and for HLA-Class-II from 531. Patients who became ill between March 2020 and August 2021 were tested for the 22 most common HLA class I (HLA-A, -B, -C) or HLA class II (HLA –DRB1/3/4, -DQA1, -DQB1) haplotypes in this collective. The identified HLA haplotypes were associated to disease severity. We also analyzed the influence of CCR5 and the ABO blood groups on the disease duration.Results: The influence of the HLA haplotypes on disease severity was stronger than the influence of age, sex, AB0 blood group, or wave of infection with different mutants of the virus. The presence of mutated CCR5 resulted in a longer recovery period.Conclusion: The existence of certain HLA haplotypes is associated with more severe disease..